These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9475109)

  • 1. Is p57KIP2 mutation a common mechanism for Beckwith-Wiedemann syndrome or somatic overgrowth?
    Okamoto K; Morison IM; Reeve AE; Tommerup N; Wiedemann HR; Friedrich U
    J Med Genet; 1998 Jan; 35(1):86. PubMed ID: 9475109
    [No Abstract]   [Full Text] [Related]  

  • 2. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.
    Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T
    Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p57KIP2 targeted disruption and Beckwith-Wiedemann syndrome: is the inhibitor just a contributor?
    Swanger WJ; Roberts JM
    Bioessays; 1997 Oct; 19(10):839-42. PubMed ID: 9363677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome.
    Bhuiyan ZA; Yatsuki H; Sasaguri T; Joh K; Soejima H; Zhu X; Hatada I; Morisaki H; Morisaki T; Mukai T
    Hum Genet; 1999 Mar; 104(3):205-10. PubMed ID: 10323243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New p57KIP2 mutations in Beckwith-Wiedemann syndrome.
    Hatada I; Nabetani A; Morisaki H; Xin Z; Ohishi S; Tonoki H; Niikawa N; Inoue M; Komoto Y; Okada A; Steichen E; Ohashi H; Fukushima Y; Nakayama M; Mukai T
    Hum Genet; 1997 Oct; 100(5-6):681-3. PubMed ID: 9341892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic imprinting and Beckwith-Wiedemann syndrome.
    Hatada I; Mukai T
    Histol Histopathol; 2000 Jan; 15(1):309-12. PubMed ID: 10668219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Beckwith-Wiedemann-Associated
    Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of p57(KIP2) gene mutation in Beckwith-Wiedemann syndrome.
    Gaston V; Le Bouc Y; Soupre V; Vazquez MP; Gicquel C
    Horm Res; 2000; 54(1):1-5. PubMed ID: 11182628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in overgrowth syndromes: clinical classification to molecular delineation in Sotos syndrome and Beckwith-Wiedemann syndrome.
    Cytrynbaum CS; Smith AC; Rubin T; Weksberg R
    Curr Opin Pediatr; 2005 Dec; 17(6):740-6. PubMed ID: 16282780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation.
    Lam WW; Hatada I; Ohishi S; Mukai T; Joyce JA; Cole TR; Donnai D; Reik W; Schofield PN; Maher ER
    J Med Genet; 1999 Jul; 36(7):518-23. PubMed ID: 10424811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overgrowth syndromes and genomic imprinting: from mouse to man.
    Li M; Squire JA; Weksberg R
    Clin Genet; 1998 Mar; 53(3):165-70. PubMed ID: 9630066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
    Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
    J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two-domain hypothesis in Beckwith-Wiedemann syndrome.
    Feinberg AP
    J Clin Invest; 2000 Sep; 106(6):739-40. PubMed ID: 10995782
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.
    Zhang P; Liégeois NJ; Wong C; Finegold M; Hou H; Thompson JC; Silverman A; Harper JW; DePinho RA; Elledge SJ
    Nature; 1997 May; 387(6629):151-8. PubMed ID: 9144284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor.
    Thompson JS; Reese KJ; DeBaun MR; Perlman EJ; Feinberg AP
    Cancer Res; 1996 Dec; 56(24):5723-7. PubMed ID: 8971182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of imprinted genes related to Beckwith-Wiedemann syndrome in human oocytes and preimplantation embryos.
    Shen WJ; Xing FQ; Kong LH; Chen SL; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):265-7. PubMed ID: 15952111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disomy and disease resolved?
    Hastie N
    Nature; 1997 Oct; 389(6653):785, 787. PubMed ID: 9349803
    [No Abstract]   [Full Text] [Related]  

  • 18. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
    Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
    Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular overlap in overgrowth syndromes.
    Baujat G; Rio M; Rossignol S; Sanlaville D; Lyonnet S; Le Merrer M; Munnich A; Gicquel C; Colleaux L; Cormier-Daire V
    Am J Med Genet C Semin Med Genet; 2005 Aug; 137C(1):4-11. PubMed ID: 16010674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased CDKN1C Expression in Congenital Alveolar Rhabdomyosarcoma Associated with Beckwith-Wiedemann Syndrome.
    Piersigilli F; Auriti C; Mondì V; Francalanci P; Salvatori G; Danhaive O
    Indian J Pediatr; 2016 Nov; 83(12-13):1476-1478. PubMed ID: 27345568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.